Patent number: 7255900
Abstract: In the compound of the formula (I), where: R1, R2 are each independently, for example, H or a straight-chain or branched alkyl radical p, q are each independently 0 or 1, i.e. at the value zero, —H is present at the appropriate position instead of —F M1 is —CO—O—, —O—CO—, —CH2—O—, —O—CH2—, —CF2—O—, —O—CF2—, —CH?CH—, —CF?CF—, —C?C—, —CH2—CH2—CO——O—, —O—CO—CH2—CH2—, —CH2—CH2—, —CF2—CF2—, —(CH2)4—, —OC(?O)CF?CF— or a single bond A1 is, for example, 1,4-phenylene R5 has the same possible definitions as specified for R1 and R2, with the exception of —M1—A1—R5, but independently of the definition of R1 and R2 X is H, F, OF3, CF3, OCF2H with the following provisos: a) at least one of p, q has to be 1 b) R1 and R2 must not at the same time be H c) R2 and X must not at the same time be H.
Type:
Grant
Filed:
April 28, 2005
Date of Patent:
August 14, 2007
Assignee:
Merck Patent GmbH
Inventors:
Wolfgang Schmidt, Rainer Wingen, Barbara Hornung
Patent number: 7244846
Abstract: Compounds of the formula (I), in which D, R1, R2 and n are defined in Claim 1, are potent 5-HT1A agonists and 5-HT reuptake inhibitors and are suitable for the treatment of depression, anxiety states, panic attacks, obsessive-compulsive disorders, psychiatric illnesses, cerebral infarction, cerebral ischaemia, tension states, side-effects in the treatment of high blood pressure, for the prophylaxis and therapy of cerebral illnesses, acromegaly, hypogonadism, secondary amenorrhoea, premenstrual syndrome, undesired puerperal lactation, pain, sleep disorders, narcolepsy, bipolar illnesses, mania, dementia, addiction illnesses, sexual dysfunction, eating disorders, obesity or fibromyalgia
Type:
Grant
Filed:
February 27, 2002
Date of Patent:
July 17, 2007
Assignee:
Merck Patent GmbH
Inventors:
Dieter Dorsch, Henning Boettcher, Christoph van Amsterdam, Wilfried Rautenberg, Gerd Bartoszyk